parexel international corp
(PRXL:Consolidated Issue Listed on NASDAQ Global Select )
Mark A. Goldberg M.D.
President and Chief Operating Officer, PAREXEL International Corporation
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2014
Dr. Mark A. Goldberg, M.D., has been the President and Chief Operating Officer of PAREXEL International Corporation since July 1, 2012 and July 2008 respectively. Dr. Goldberg served as Chief Operating Officer of Parexel Informatics, Inc. He served in management capacities of increasing responsibility at Genzyme from 1996 to 2011, including as Senior Vice President for Clinical Development and Global Therapeutic Group Head for Oncology and Personalized Genetic Health. ...
195 West StreetPhone: 781-487-9900
Waltham, Massachusetts 02451
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
The University of Massachusetts Medical School
|James C. Foster J.D.||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee|
Charles River Laboratories International, Inc.
|Ciaran Murray||Chief Executive Officer, Director and Chairman of Executive Committee|
ICON Public Limited Company
|Matthias Hartmann||Chief Executive Officer and Member of Management Board|
|Ge Li Ph.D.||Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee|
WuXi PharmaTech (Cayman) Inc.
|Ping Ye Xiao M.D., D.Phil, EMBA||Chairman, Chief Executive Officer and General Manager|
Hangzhou Tigermed Consulting Co., Ltd.
|--||Compensation as of Fiscal Year 2014.|